46
Participants
Start Date
September 30, 2014
Primary Completion Date
December 31, 2014
Study Completion Date
December 31, 2014
Meropenem
To administer 2g daily 8 hourly for 14 days
Faropenem
To adminster 600mg 8 hourly daily for 14 days
Amoxycillin/clavulanic acid
To administer 625mg 8 hourly daily for 14 days together with the faropenem and meropenem
Rifafour e275
To be taken as per the National TB treatment programme for 14 days
TASK Foundation NPC, Cape Town
Collaborators (1)
Eduardo Mondlane University
OTHER
GlaxoSmithKline
INDUSTRY
Barcelona Centre for International Health Research
OTHER
Research Center Borstel
OTHER
TASK Applied Science
OTHER